Premium
Next‐generation sequencing assay in salivary gland cytology: A pilot study
Author(s) -
Yamamoto Shuhei,
Sakamoto Yuma,
Nakano Satsuki,
Fujii Keiichiro,
Ueda Kaori,
Okumura Yoshihide,
Tsuda Kana,
Masaki Ayako,
Kawakita Daisuke,
Murase Takayuki,
Inagaki Hiroshi
Publication year - 2020
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/jop.13109
Subject(s) - malignancy , cytology , medicine , pathology , cytopathology , fine needle aspiration cytology
Background Preoperative diagnosis of salivary gland tumors (SGTs) by fine‐needle aspiration (FNA) cytology is challenging. Next‐generation sequencing (NGS)‐based assays for somatic mutations have a great advantage in that a large number of genes can be analyzed simultaneously. Although NGS may have an enormous diagnostic potential in cytology, to our knowledge, the significance of NGS in SGT cytology remains to be clarified. Methods In this pilot study, we retrospectively examined 32 frozen SGT samples obtained at surgery (14 malignant and 18 benign). After the stored frozen tumor tissues were thawed, aspirate samples were obtained using 22‐gauge needles and subjected to smear tumor samples and to DNA extraction for an NGS assay employing the Illumina AmpliSeq Cancer Hotspot Panel v2. The results were correlated to preoperative cytological diagnosis. Results The preoperative diagnoses obtained by FNA cytology included 23 negative lesions (no malignancy in 6 and benign tumor in 17) and nine positive lesions (suspicious for malignancy in 4 and malignancy in five), providing a sensitivity and a specificity of 9/14 (64%) and 18/18 (100%), respectively. The NGS assay detected somatic mutations in 10/14 malignant and 1/18 benign SGT cases, providing a sensitivity and a specificity of 71% and 94%, respectively. Conclusion The NGS assay may be helpful for detecting the malignant potential in SGT cases and can be used as an ancillary test for SGT cytology.